Canada authorizes Johnson & Johnson’s Janssen vaccine
Its efficacy is 66%, while the Pfizer and Moderna vaccines are around 95% effective.
The regulatory agency of Canada has approved the use of the fourth vaccine against coronavirus – Janssen developed by Johnson & Johnson. Unlike others, this vaccine requires only one injection of the drug, Ukrinform reports, citing data from the Health Canada Department.
“As with all other COVID vaccines, the Department of Health approved Jansen vaccine after an independent and rigorous scientific study of its safety, efficacy and quality. After reviewing all the data, we concluded that there is strong evidence that the benefits of this vaccine outweigh its potential risks.” , – said in the Ministry of Health of the country.
It is noted that the government allowed the use of the vaccine for all people over 18 years old.
Canada has already ordered 10 million doses of the vaccine and has the ability to purchase another 18 million. The vaccines will be supplied from Johnson & Johnson’s facilities in Europe and the United States.
Tests in which 44 thousand people took part showed that the effectiveness of the Johnson & Johnson vaccine is 66%, while the Pfizer and Moderna vaccines have this figure of about 95%.
Unlike others, Johnson & Johnson’s vaccine only requires one dose. It can be stored in a regular refrigerator, which makes it easier to transport and distribute the drug.
By the way, the vaccine shortage in Canada is now so acute that provincial governments are now saying they will extend the interval between two doses of Pfizer, Moderna and AstraZeneca vaccines by four months, rather than three to four weeks, so that they can quickly vaccinate more people.
It was previously reported that Johnson & Johnson Applies for EU COVID Vaccine Authorization.
News from Correspondent.net in Telegram. Subscribe to our channel https://t.me/korrespondentnet